Iotech has developed a core, proprietary, patent protected technology that is unique, best-in-class and addresses hundreds of applications in multi-billion dollar markets. The products developed from this technology are state-of the-art antimicrobials that are uniquely effective in killing bacteria, viruses, fungi and spores with a speed, precision and safety margins that are unavailable in any other product. These products have patents applied for globally and will be marketed throughout the world.

Initial product opportunities: Fruit & Vegetable Sanitizer and Shelf Life Extender, Consumer, Surface Disinfectant, Hospital Surface Disinfectant, Professional Dental Products to treat/prevent periodontal (gum) disease. Each of these products address markets greater than $ 1 billion.

Additional Product Opportunities: Hand sanitizers, mouthwash, breath fresheners, throat gargle, anti-cavity toothpaste, ear drops, eye drops, sinus/nasal sprays, skin creams and lotions, liquid chemical sterilants, antiseptics, surgical scrubs, veterinary use, wound/burn disinfection, food processing applications, meat, dairy and seafood shelf-life extender,  aquaculture, cold, flu, sore throat treatment/preventative, anti-bacterial soaps and detergents, preservatives and dozens of other applications.

1. Worldwide patent applications applied for.

2. Extensive efficacy and toxicity testing accomplished and documented by EPA and FDA-certified laboratories.

3. Efficacy qualification to market a hand sanitizer in EU.

4. No regulatory approval neededto market initial product for $ 1 billion plus market.

5. Three months away from initial product launch.

6. Follow-on two products require only EPA approval ( a 4-5 month approval process)

Our products combine the broadest spectrum of action, fastest speed of action and best safety profile of any other product in the world. These features, coupled with extremely large profit margins, allow us to produce products that are custom tailored to each application with best-in-class performance at competitive prices. Our patent- pending protection worldwide and multiple $ billion plus markets suggest a very favorable reward:risk ratio for our investors.